Timothy Block

Develops drug therapy for treatment of chronic liver diseases

Operates as a non-profit organization for liver cancer awareness

Functions as a College/University

Operates as a non-profit research organization

The Baruch S. Blumberg Institute is a nonprofit translational research organization dedicated to curing hepatitis B and liver cancer. The non-profit company is based in Doylestown, PA. The institute conducts multidisciplinary research in virology, antiviral drug discovery, biopharmaceutics (including RNA and gene-editing therapeutics), precision medicine, cancer and regenerative medicine, and public health focused on eliminating health disparities related to hepatitis B. It operates within a collaborative ecosystem alongside the Hepatitis B Foundation and the Pennsylvania Biotechnology Center, and manages B+Labs, which provides wet lab and office space to support innovation and entrepreneurship in life sciences. The institute offers training programs such as summer internships, high school science enrichment, AP chemistry mentorships, and post-graduate education, and hosts a seminar series to promote scientific exchange and collaboration. It partners with academic institutions and patient communities to integrate research, education, and advocacy, and is supported by donor contributions to advance research, education, and public health efforts for hepatitis B, liver cancer, and related viral diseases. The company was founded by Timothy M. Block.

Develops unique and non-invasive blood tests for liver cancers and fibrosis-cirrhosis

Hatch Biofund Management invests in companies located in the United States. The firm focuses on the biotechnology sectors. it participates in the early stage capital requirements.